Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs).
Natco Pharma Limited, is a listed public company incorporated on 19 September, 1981. It is classified as a public limited company and is located in , Telangana. It's authorized share capital is INR 45.00 cr and the total paid-up capital is INR 35.82 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Potluri Prasad Sivaramakrishna
Shareholder
|
07011140 | 11 years |
| Whole-time Director | Lingarao Donthineni
Shareholder
|
07088404 | 11 years |
| Managing Director | Venkaiah Chowdary Nannapaneni
Shareholder
|
00183315 | 11 years |
| Whole-time Director | Rajeev Nannapaneni
Shareholder
|
00183872 | 14 years |
| Director | Nitin Jain | 00136245 | 1 years |
| Director | Suma Kantipudi | 02734369 | 1 years |
| Director | Lakshminarayana Bolisetty | 02766709 | 1 years |
| Director | Agnihotra Dakshina Murty Chavali | 00374673 | 2 years |
| Director | Vijayabhaskar Dronadula | 07158951 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 600.0 cr
Allahabad Bank
No. of Loans: 1
Total Amount : 520.0 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Natco Pharma Inc | United States | - | - |
| Natco Pharma (Canada) Inc | Canada | - | - |
| Time Cap Overseas Limited | Mauritius | - | - |
| NATCO Pharma Asia PTE Ltd | Singapore | - | - |
| NATCO Pharma Australia PTY Ltd | Australia | - | - |
| NATCO Farma Do Brazil Ltd | Brazil | - | - |
| NATCO Lifesciences Philippines Inc | Philippines | - | - |
| NATCO PHARMA USA LLC | United States | - | - |
| NATCO Pharma UK Limited | United Kingdom | - | - |
| PT. NATCO Lotus Farma | Indonesia | - | - |
| NATCO Pharma COLOMBIA S.A.S. | Colombia | - | - |
| Natco Pharma (canada) Inc | Canada | - | - |
| Time Cap Overseas Limited | Mauritius | - | - |
| NATCO Pharma Australia PTY Ltd | Australia | - | - |
| NATCO Farma Do Brazil Ltd | Brazil | - | - |
| NATCO Lifesciences Philippines Inc | Philippines | - | - |
| NATCO Pharma Asia PTE Ltd | Singapore | - | - |
| NATCO PHARMA USA LLC | United States | - | - |
| NATCO Pharma UK Limited | United Kingdom | - | - |
| PT. NATCO Lotus Farma | Indonesia | - | - |
| NATCO Pharma COLOMBIA S.A.S. | Colombia | - | - |
Read more
The incorporation date of NATCO PHARMA LIMITED is 19 September, 1981
The authorized share capital of NATCO PHARMA LIMITED is INR ₹ 45.0 Cr.
The paid-up capital of NATCO PHARMA LIMITED is INR ₹ 35.8 Cr.
The registered address of NATCO PHARMA LIMITED is Natco House , Road No.2, Banjara hills, Hyderabad, Hyderabad, Telangana, India, 500034 - 500034
The CIN number of NATCO PHARMA LIMITED is L24230TG1981PLC003201.